Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
103 USD | +0.79% | -0.54% | +2.16% |
07:04pm | Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118 | MT |
02:30pm | Transcript : Cardinal Health, Inc., Q3 2024 Earnings Call, May 02, 2024 |
Evolution of the average Target Price on Cardinal Health, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cardinal Health, Inc.
Wells Fargo Securities | |
Evercore ISI | |
Morgan Stanley | |
Leerink Partners | |
Argus | |
UBS | |
JPMorgan Chase | |
Deutsche Bank Securities | |
Nephron Research | |
Morningstar | |
TD Cowen | |
Mizuho Securities | |
Baird | |
Citigroup | |
Barclays | |
Credit Suisse | |
Cowen | |
BofA Securities |
EPS Revisions
- Stock Market
- Equities
- CAH Stock
- Consensus Cardinal Health, Inc.